Variants of Dopamine Beta Hydroxylase Gene Moderate Atomoxetine Response in Children with Attention-Deficit/Hyperactivity Disorder.

about

Pharmacogenetics of Dopamine β-Hydroxylase in cocaine dependence therapy with doxazosin.

P2860

Q51745354-6D05982B-CF1B-4C9D-A7DB-734A35CDEB83

P2860

Variants of Dopamine Beta Hydroxylase Gene Moderate Atomoxetine Response in Children with Attention-Deficit/Hyperactivity Disorder.

Item

http://www.wikidata.org/entity/Q36191809

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Variants of Dopamine Beta Hydr ...... eficit/Hyperactivity Disorder.

@ast

Variants of Dopamine Beta Hydr ...... eficit/Hyperactivity Disorder.

@en

type

Item

label

Variants of Dopamine Beta Hydr ...... eficit/Hyperactivity Disorder.

@ast

Variants of Dopamine Beta Hydr ...... eficit/Hyperactivity Disorder.

@en

prefLabel

Variants of Dopamine Beta Hydr ...... eficit/Hyperactivity Disorder.

@ast

Variants of Dopamine Beta Hydr ...... eficit/Hyperactivity Disorder.

@en

P1476

Variants of Dopamine Beta Hydr ...... eficit/Hyperactivity Disorder.

@en

P2093

Li Yang

http://www.w3.org/2001/XMLSchema#string

Min Chen

http://www.w3.org/2001/XMLSchema#string

Ning Ji

http://www.w3.org/2001/XMLSchema#string

Qingjiu Cao

http://www.w3.org/2001/XMLSchema#string

Yantong Fang

http://www.w3.org/2001/XMLSchema#string

Yi Su

http://www.w3.org/2001/XMLSchema#string

Yufeng Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder

Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment.

Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics.

A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder

Association of the dopamine beta hydroxylase gene with attention deficit hyperactivity disorder: genetic analysis of the Milwaukee longitudinal study.

Possible association of norepinephrine transporter -3081(A/T) polymorphism with methylphenidate response in attention deficit hyperactivity disorder

Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder.

LD Score regression distinguishes confounding from polygenicity in genome-wide association studies

Involvement of norepinephrine in the control of activity and attentive processes in animal models of attention deficit hyperactivity disorder

Molecular genetics of attention-deficit/hyperactivity disorder.

P304

625-632

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/CAP.2014.0178

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26447643

http://www.w3.org/2001/XMLSchema#string

P932

4615817

http://www.w3.org/2001/XMLSchema#string

Variants of Dopamine Beta Hydroxylase Gene Moderate Atomoxetine Response in Children with Attention-Deficit/Hyperactivity Disorder.

about

P2860

P2860

Variants of Dopamine Beta Hydroxylase Gene Moderate Atomoxetine Response in Children with Attention-Deficit/Hyperactivity Disorder.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932